Prilenia, a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, has filed a European Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for Lue lisää...
I belong to the third generation of a family affected by Huntington’s Disease, but it wasn’t until 2024, thanks to the tireless efforts of my second father, F. Cook, that we were able to confirm how the disease entered the Lue lisää...
Abu Dhabi, UAE; June 19, 2024: IROS, an Abu Dhabi-based contract research organization (part of the M42 group), has partnered with Prilenia Therapeutics, a clinical-stage biotech company, and the International Huntington’s Disease Association (IHA) to plan the first-ever clinical trial Lue lisää...
“We are very pleased with these new data demonstrating a statistically significant, dose-dependent slowing of the progression of Huntington’s disease and lowering of NfL in the CSF at 24 months,” stated Walid Abi-Saab, M.D., chief medical officer of uniQure. “We believe Lue lisää...
Today, Wave Life Sciences announced positive results from SELECT-HD, our Phase 1b/2a placebo-controlled trial evaluating the investigational therapy WVE-003. These results demonstrate that WVE-003 selectively lowers toxic, mutant huntingtin (mHTT) protein and preserves healthy, wild-type huntingtin (wtHTT) protein for individuals Lue lisää...
At Month 12, mutant Huntingtin (mHTT) in the blood was lowered by 22% and 43% respectively for 5mg and 10mg doses. A similar result was seen in cerebrospinal fluid, where mHTT was lowered by 21% and 43% respectively, for 5mg Lue lisää...
Earlier this week Sage Therapeutics announced the results of their SURVEYOR study which quantified the cognitive impact of Huntington’s Disease. Using the HD-Cognitive Assessment Battery (HD-CAB) they measured the difference between 29 healthy volunteers and 40 participants with HD. As Lue lisää...
IHA:n puheenjohtaja Svein Olaf Olsen oli pääpuhuja Huntingtonin taudista MENA:n harvinaisten sairauksien kongressissa Abu Dhabissa viime kuussa. Hän puhui kiireellisestä tarpeesta perustaa alueelle neurodegeneratiivisten sairauksien osaamiskeskus. Lue lisää...
Nykyään olemme hyvin onnellisia Huntingtonin yhteisössä. Uniquren ilmoitus siitä, että yhtiö on saanut Regenerative Medicine Advanced Therapy (RMAT) -nimityksen Huntingtonin tautia tutkivalle geeniterapialle AMT-130:lle, on enemmän kuin lupaava", sanoo presidentti Lue lisää...
Muistelmateoksessaan "We Exist" Tanita Allen kertoo vaikeuksista, joita hänellä oli, kun hänen oireensa diagnosoitiin oikein Huntingtonin taudiksi. Hänet diagnosoitiin kerta toisensa jälkeen väärin, koska lääkärit kieltäytyivät ottamasta huomioon, että myös afroamerikkalaiset voivat periä mutatoituneen sairauden. Lue lisää...
Finnish 
English 
Arabic 
Bulgarian 
Chinese 
Czech 
Danish 
Dutch 
Estonian 
French 
German 
Greek 
Hungarian 
Indonesian 
Italian 
Japanese 
Latvian 
Lithuanian 
Polish 
Portuguese 
Romanian 
Russian 
Slovak 
Slovenian 
Spanish 
Swedish 
Turkish 
Ukrainian